chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bedridden, Bladder pain, Fatigue, Feeling abnormal
Clinical narrative: Brain fog, could not think straight for 2 weeks I had to write things down to function; Memory issues; Blurred vision; Bladder pain, its terrible; Ringing in my ears; I was pretty much bedridden for several days; Heart Palpitations; Joint pain; Fatigue; Muscle and joint pain, still comes in waves; Extreme headaches, severe, lasted 7 days; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fog, could not think straight for 2 weeks I had to write things down to function), MEMORY IMPAIRMENT (Memory issues), VISION BLURRED (Blurred vision), BLADDER PAIN (Bladder pain, its terrible) and TINNITUS (Ringing in my ears) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 025620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included HYDROCHLOROTHIAZIDE;LOSARTAN, LEVOTHYROXINE and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Brain fog, could not think straight for 2 weeks I had to write things down to function), MEMORY IMPAIRMENT (Memory issues), VISION BLURRED (Blurred vision), BLADDER PAIN (Bladder pain, its terrible), TINNITUS (Ringing in my ears), BEDRIDDEN (I was pretty much bedridden for several days), PALPITATIONS (Heart Palpitations), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), MYALGIA (Muscle and joint pain, still comes in waves) and HEADACHE (Extreme headaches, severe, lasted 7 days). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Brain fog, could not think straight for 2 weeks I had to write things down to function), MEMORY IMPAIRMENT (Memory issues), VISION BLURRED (Blurred vision), BLADDER PAIN (Bladder pain, its terrible), TINNITUS (Ringing in my ears), BEDRIDDEN (I was pretty much bedridden for several days), PALPITATIONS (Heart Palpitations), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), MYALGIA (Muscle and joint pain, still comes in waves) and HEADACHE (Extreme headaches, severe, lasted 7 days) outcome was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Memory impairment, Myalgia, Palpitations, Tinnitus
Clinical narrative: Brain fog, could not think straight for 2 weeks I had to write things down to function; Memory issues; Blurred vision; Bladder pain, its terrible; Ringing in my ears; I was pretty much bedridden for several days; Heart Palpitations; Joint pain; Fatigue; Muscle and joint pain, still comes in waves; Extreme headaches, severe, lasted 7 days; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fog, could not think straight for 2 weeks I had to write things down to function), MEMORY IMPAIRMENT (Memory issues), VISION BLURRED (Blurred vision), BLADDER PAIN (Bladder pain, its terrible) and TINNITUS (Ringing in my ears) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 025620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included HYDROCHLOROTHIAZIDE;LOSARTAN, LEVOTHYROXINE and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Brain fog, could not think straight for 2 weeks I had to write things down to function), MEMORY IMPAIRMENT (Memory issues), VISION BLURRED (Blurred vision), BLADDER PAIN (Bladder pain, its terrible), TINNITUS (Ringing in my ears), BEDRIDDEN (I was pretty much bedridden for several days), PALPITATIONS (Heart Palpitations), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), MYALGIA (Muscle and joint pain, still comes in waves) and HEADACHE (Extreme headaches, severe, lasted 7 days). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Brain fog, could not think straight for 2 weeks I had to write things down to function), MEMORY IMPAIRMENT (Memory issues), VISION BLURRED (Blurred vision), BLADDER PAIN (Bladder pain, its terrible), TINNITUS (Ringing in my ears), BEDRIDDEN (I was pretty much bedridden for several days), PALPITATIONS (Heart Palpitations), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), MYALGIA (Muscle and joint pain, still comes in waves) and HEADACHE (Extreme headaches, severe, lasted 7 days) outcome was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Brain fog, could not think straight for 2 weeks I had to write things down to function; Memory issues; Blurred vision; Bladder pain, its terrible; Ringing in my ears; I was pretty much bedridden for several days; Heart Palpitations; Joint pain; Fatigue; Muscle and joint pain, still comes in waves; Extreme headaches, severe, lasted 7 days; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fog, could not think straight for 2 weeks I had to write things down to function), MEMORY IMPAIRMENT (Memory issues), VISION BLURRED (Blurred vision), BLADDER PAIN (Bladder pain, its terrible) and TINNITUS (Ringing in my ears) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 025620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included HYDROCHLOROTHIAZIDE;LOSARTAN, LEVOTHYROXINE and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Brain fog, could not think straight for 2 weeks I had to write things down to function), MEMORY IMPAIRMENT (Memory issues), VISION BLURRED (Blurred vision), BLADDER PAIN (Bladder pain, its terrible), TINNITUS (Ringing in my ears), BEDRIDDEN (I was pretty much bedridden for several days), PALPITATIONS (Heart Palpitations), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), MYALGIA (Muscle and joint pain, still comes in waves) and HEADACHE (Extreme headaches, severe, lasted 7 days). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Brain fog, could not think straight for 2 weeks I had to write things down to function), MEMORY IMPAIRMENT (Memory issues), VISION BLURRED (Blurred vision), BLADDER PAIN (Bladder pain, its terrible), TINNITUS (Ringing in my ears), BEDRIDDEN (I was pretty much bedridden for several days), PALPITATIONS (Heart Palpitations), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), MYALGIA (Muscle and joint pain, still comes in waves) and HEADACHE (Extreme headaches, severe, lasted 7 days) outcome was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy bone marrow, Blood test, Bronchoscopy, Computerised tomogram, Lymphoma
Clinical narrative: Probable lymphoma
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Positron emission tomogram
Clinical narrative: Probable lymphoma
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case admission
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Urticaria
Clinical narrative: I was fine immediately after. On 2/22/2022, my hands got itchy, red and swollen. This passed in about an hour. Thursday night, 2/24/2022, my entire body broke-out in hives. This has not stopped since. I've taken Claritin, Benadryl and calamine lotion. The itching does not stop. I have very obvious welts all over my body with itching. Now this is beginning on my face. I am concerned that this issue does not stop.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: event occurred after 2nd vaccine; breakthrough case admission
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after Janssen vaccine; breakthrough case admission
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram, Computerised tomogram, Headache, Hypoaesthesia, Magnetic resonance imaging
Clinical narrative: vision problems, headache, facial numbness Hospitalization ,  Ophthalmologist Still have vision problems
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: vision problems, headache, facial numbness Hospitalization ,  Ophthalmologist Still have vision problems
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: None reported
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case admission
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: event occurred after 2nd vaccine; breakthrough case admission
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case admission
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case admission
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case admission
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: event occurred after 3rd vaccine; breakthrough case admission
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Product dose omission issue
Clinical narrative: more than 10 weeks since her first dose; minor soreness in her left arm which took her down for a few days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (more than 10 weeks since her first dose) and MYALGIA (minor soreness in her left arm which took her down for a few days) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (more than 10 weeks since her first dose) and MYALGIA (minor soreness in her left arm which took her down for a few days). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PRODUCT DOSE OMISSION ISSUE (more than 10 weeks since her first dose) and MYALGIA (minor soreness in her left arm which took her down for a few days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 2nd parent missed 2nd dose, past 36 days.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd parent missed 2nd dose, past 36 days.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd parent missed 2nd dose, past 36 days.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (2nd parent missed 2nd dose, past 36 days.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided. No treatment medications were not provided.   This case was linked to US-irms-MOD21-269732 (E2B Linked Report).; Sender's Comments:  US-irms-MOD21-269732:
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: More than 36 days after the first dose without receiving the second dose/5 months after the first dose, Not received the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 36 days after the first dose without receiving the second dose/5 months after the first dose, Not received the 2nd dose) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     The patient's past medical history included Immune thrombocytopenia (He states that he has a preexisting health condition of Immune thrombocytopenia (ITP) due to a flu virus. He states he is in remission so he has gone about the low level (it is 100000 and he is now at 125000 or 150000).).    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 36 days after the first dose without receiving the second dose/5 months after the first dose, Not received the 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 36 days after the first dose without receiving the second dose/5 months after the first dose, Not received the 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.  Patient states that he has a preexisting health condition of Immune thrombocytopenia (ITP) due to a flu virus and he is in remission so he has gone about the low level (it is 100000 and he is now at 125000 or 150000).   Most recent FOLLOW-UP information incorporated above includes: On 16-Sep-2021: Significant Follow up received on 16-SEP-2021 and batch number is updated.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Hypokinesia, Neck pain, Pain in extremity
Clinical narrative: Pain on the Left arm, entire upper back , legs, and both side of the neck; Can not move neck to the left or right/"The vaccine Paralyzed my neck"; Pain on the Left arm, entire upper back , legs, and both side of the neck; Pain on the Left arm, entire upper back , legs, and both side of the neck; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on the Left arm, entire upper back , legs, and both side of the neck), HYPOKINESIA (Can not move neck to the left or right/"The vaccine Paralyzed my neck"), BACK PAIN (Pain on the Left arm, entire upper back , legs, and both side of the neck) and NECK PAIN (Pain on the Left arm, entire upper back , legs, and both side of the neck) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jul-2021, the patient experienced PAIN IN EXTREMITY (Pain on the Left arm, entire upper back , legs, and both side of the neck), HYPOKINESIA (Can not move neck to the left or right/"The vaccine Paralyzed my neck"), BACK PAIN (Pain on the Left arm, entire upper back , legs, and both side of the neck) and NECK PAIN (Pain on the Left arm, entire upper back , legs, and both side of the neck). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain on the Left arm, entire upper back , legs, and both side of the neck), HYPOKINESIA (Can not move neck to the left or right/"The vaccine Paralyzed my neck"), BACK PAIN (Pain on the Left arm, entire upper back , legs, and both side of the neck) and NECK PAIN (Pain on the Left arm, entire upper back , legs, and both side of the neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided. Treatment information was not provided.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: HCP reported two patients received a mixed product series; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (HCP reported two patients received a mixed product series) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 27-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1. On 27-Jul-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (HCP reported two patients received a mixed product series). On 27-Jul-2021, INTERCHANGE OF VACCINE PRODUCTS (HCP reported two patients received a mixed product series) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drug was not reported. Treatment medication was not reported.  It was reported that 2 patients received Moderna COVID-19 Vaccine as second dose and J &J/ Pfizer's COVID-19 vaccine dose as dose 1 respectively.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient was underage at the time of vaccination; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was underage at the time of vaccination) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was underage at the time of vaccination). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was underage at the time of vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case reported by a pharmacist, describes the occurrence of administered expired product (received a dose of the Moderna COVID-19 vaccine expired on July 25th) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 004C21A) for COVID-19 immunization. No medical history reported. On Jun 29, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jul 27, 2021, received second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jul 27, 2021, patient experienced administered expired product (received a dose of the Moderna COVID-19 vaccine expired on July 25th). At the time of the report, administered expired product (received a dose of the Moderna COVID-19 vaccine expired on July 25th): resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: increased contact site reaction; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE REACTION (increased contact site reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: TDAP (The patient received a T-dap shot first and then approximately 2 weeks later the patient received the Moderna COVID-19 vaccine.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (increased contact site reaction). At the time of the report, VACCINATION SITE REACTION (increased contact site reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow-up information received contained non-significant information.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 12 year old received the Moderna Covid 19 Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old received the Moderna Covid 19 Vaccine) in a 12-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old received the Moderna Covid 19 Vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old received the Moderna Covid 19 Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Nausea, Pyrexia
Clinical narrative: Hot a lot; Feeling nausea; Slight elevation in temperature; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hot a lot), NAUSEA (Feeling nausea) and PYREXIA (Slight elevation in temperature) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 017B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Hot a lot), NAUSEA (Feeling nausea) and PYREXIA (Slight elevation in temperature). At the time of the report, FEELING HOT (Hot a lot), NAUSEA (Feeling nausea) and PYREXIA (Slight elevation in temperature) outcome was unknown.            It was reported that the patient was taking other unknown concominant medications which were not provided. Patient stated that on 04/05 Jul-021, she was near someone who is not vaccinated, that had just been out of the hospital. About 4 or 5 days she been feeling nausea, hot a lot, and a slight elevation in temperature. She is wondering if she had a breakthrough. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received a dose of the Moderna COVID-19 Vaccine that expired on July 25th; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004C21A and 014C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received a dose on day 30 after the expiration time; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a dose on day 30 after the expiration time) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a dose on day 30 after the expiration time). On 25-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Received a dose on day 30 after the expiration time) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Pharmacist reported that they gave five doses of the Moderna COVID-19 vaccine from a expired vial. They gave those dose on the 30th day (25-Jul-2021) after the time it expired that was 10:11 AM.  The vial was initially stored in the refrigerator on 25-Jun-2021. The vial did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77° F): On 25-Jul-2021 it was exposed to room temperature from 10:30 AM to 16:30 PM.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Additional information received: Patient initials updated.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received a dose of the Moderna COVID-19 Vaccine that expired on July 25th; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th). On 26-Jul-2021, EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment information was not reported..   This case was linked to MOD21-124492, MOD21-124485, MOD21-124297, MOD21-124406, MOD21-124409, MOD21-124481, MOD21-124417, MOD21-124423, MOD21-124424, MOD21-124434, MOD21-124447, MOD21-124492 (Patient Link).
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Product dose omission issue, Pruritus, Pyrexia, Rash
Clinical narrative: Has not received his 2nd dose; Full body hives/ had hives; He was feeling itchy/ feeling fully itchy; He was really in a bad shape for 2-3 days; He had a little bad reaction to the vaccine/ "all that stuff"; Fever; rash; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not received his 2nd dose), URTICARIA (Full body hives/ had hives), PRURITUS (He was feeling itchy/ feeling fully itchy), FEELING ABNORMAL (He was really in a bad shape for 2-3 days) and VACCINATION COMPLICATION (He had a little bad reaction to the vaccine/ "all that stuff") in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included LOSARTAN and HYDROCHLOROTHIAZIDE for Blood pressure management.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced URTICARIA (Full body hives/ had hives), FEELING ABNORMAL (He was really in a bad shape for 2-3 days), VACCINATION COMPLICATION (He had a little bad reaction to the vaccine/ "all that stuff") and RASH (rash). March 2021, the patient experienced PRURITUS (He was feeling itchy/ feeling fully itchy) and PYREXIA (Fever). On 23-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received his 2nd dose). In March 2021, URTICARIA (Full body hives/ had hives), PRURITUS (He was feeling itchy/ feeling fully itchy), FEELING ABNORMAL (He was really in a bad shape for 2-3 days), VACCINATION COMPLICATION (He had a little bad reaction to the vaccine/ "all that stuff"), PYREXIA (Fever) and RASH (rash) had resolved. On 23-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Has not received his 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient's doctor prescribed him Prednisone but he didn't take it, as symptoms resolved in 2-3 days themselves without treatment.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria, Vaccination complication
Clinical narrative: Has not received his 2nd dose; Full body hives/ had hives; He was feeling itchy/ feeling fully itchy; He was really in a bad shape for 2-3 days; He had a little bad reaction to the vaccine/ "all that stuff"; Fever; rash; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not received his 2nd dose), URTICARIA (Full body hives/ had hives), PRURITUS (He was feeling itchy/ feeling fully itchy), FEELING ABNORMAL (He was really in a bad shape for 2-3 days) and VACCINATION COMPLICATION (He had a little bad reaction to the vaccine/ "all that stuff") in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included LOSARTAN and HYDROCHLOROTHIAZIDE for Blood pressure management.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced URTICARIA (Full body hives/ had hives), FEELING ABNORMAL (He was really in a bad shape for 2-3 days), VACCINATION COMPLICATION (He had a little bad reaction to the vaccine/ "all that stuff") and RASH (rash). March 2021, the patient experienced PRURITUS (He was feeling itchy/ feeling fully itchy) and PYREXIA (Fever). On 23-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received his 2nd dose). In March 2021, URTICARIA (Full body hives/ had hives), PRURITUS (He was feeling itchy/ feeling fully itchy), FEELING ABNORMAL (He was really in a bad shape for 2-3 days), VACCINATION COMPLICATION (He had a little bad reaction to the vaccine/ "all that stuff"), PYREXIA (Fever) and RASH (rash) had resolved. On 23-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Has not received his 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient's doctor prescribed him Prednisone but he didn't take it, as symptoms resolved in 2-3 days themselves without treatment.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: caller states they know both male patients that have joint and muscle pain that got the vaccine; caller states they know both male patients that have joint and muscle pain that got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (caller states they know both male patients that have joint and muscle pain that got the vaccine) and ARTHRALGIA (caller states they know both male patients that have joint and muscle pain that got the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (caller states they know both male patients that have joint and muscle pain that got the vaccine) and ARTHRALGIA (caller states they know both male patients that have joint and muscle pain that got the vaccine). At the time of the report, MYALGIA (caller states they know both male patients that have joint and muscle pain that got the vaccine) and ARTHRALGIA (caller states they know both male patients that have joint and muscle pain that got the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment information was reported.   This case was linked to MOD-2021-269810 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysgeusia, Intentional product use issue, Lymphadenopathy, Pain
Clinical narrative: She does not get the second shot; Hard time tasting; Had her normal cereal and it tasted salty; A swollen lymph node underneath her armpit; It hurts; Swollen and painful lymph node along her pelvic area; Arm was sore; A little dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (A little dizzy), PAIN IN EXTREMITY (Arm was sore), PAIN (It hurts), PELVIC PAIN (Swollen and painful lymph node along her pelvic area) and TASTE DISORDER (Hard time tasting) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01911219) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included ETHINYLESTRADIOL, NORELGESTROMIN (ORTHO EVRA) and LORAZEPAM for an unknown indication.    On 18-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jul-2021, the patient experienced DIZZINESS (A little dizzy). On 19-Jul-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 22-Jul-2021, the patient experienced PAIN (It hurts), PELVIC PAIN (Swollen and painful lymph node along her pelvic area) and LYMPHADENOPATHY (A swollen lymph node underneath her armpit). On 28-Jul-2021, the patient experienced TASTE DISORDER (Hard time tasting) and DYSGEUSIA (Had her normal cereal and it tasted salty). On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (She does not get the second shot). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency. At the time of the report, DIZZINESS (A little dizzy), PAIN IN EXTREMITY (Arm was sore), PAIN (It hurts), PELVIC PAIN (Swollen and painful lymph node along her pelvic area), TASTE DISORDER (Hard time tasting), DYSGEUSIA (Had her normal cereal and it tasted salty) and LYMPHADENOPATHY (A swollen lymph node underneath her armpit) outcome was unknown and INTENTIONAL PRODUCT USE ISSUE (She does not get the second shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not take anything for the first 3 days. The swollen and painful lymph node along her pelvic area went away and she was fine for a couple of days. She stated that she just woke up a couple hours ago and it is super swollen and hurts.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pelvic pain, Taste disorder
Clinical narrative: She does not get the second shot; Hard time tasting; Had her normal cereal and it tasted salty; A swollen lymph node underneath her armpit; It hurts; Swollen and painful lymph node along her pelvic area; Arm was sore; A little dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (A little dizzy), PAIN IN EXTREMITY (Arm was sore), PAIN (It hurts), PELVIC PAIN (Swollen and painful lymph node along her pelvic area) and TASTE DISORDER (Hard time tasting) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01911219) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included ETHINYLESTRADIOL, NORELGESTROMIN (ORTHO EVRA) and LORAZEPAM for an unknown indication.    On 18-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jul-2021, the patient experienced DIZZINESS (A little dizzy). On 19-Jul-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 22-Jul-2021, the patient experienced PAIN (It hurts), PELVIC PAIN (Swollen and painful lymph node along her pelvic area) and LYMPHADENOPATHY (A swollen lymph node underneath her armpit). On 28-Jul-2021, the patient experienced TASTE DISORDER (Hard time tasting) and DYSGEUSIA (Had her normal cereal and it tasted salty). On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (She does not get the second shot). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency. At the time of the report, DIZZINESS (A little dizzy), PAIN IN EXTREMITY (Arm was sore), PAIN (It hurts), PELVIC PAIN (Swollen and painful lymph node along her pelvic area), TASTE DISORDER (Hard time tasting), DYSGEUSIA (Had her normal cereal and it tasted salty) and LYMPHADENOPATHY (A swollen lymph node underneath her armpit) outcome was unknown and INTENTIONAL PRODUCT USE ISSUE (She does not get the second shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not take anything for the first 3 days. The swollen and painful lymph node along her pelvic area went away and she was fine for a couple of days. She stated that she just woke up a couple hours ago and it is super swollen and hurts.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: Tired; Slight chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired) and CHILLS (Slight chills) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired) and CHILLS (Slight chills). At the time of the report, FATIGUE (Tired) and CHILLS (Slight chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was reported.   This case was linked to MOD-2021-269841.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on stomach; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on stomach) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash on stomach). At the time of the report, RASH (Rash on stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Steroid shot as a treatment information provided. No concomitant medication provided. Paitent want to know advisementon the second dose, efficacy of first dose.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 13 year old received the Moderna Covid 19 Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13 year old received the Moderna Covid 19 Vaccine) in a 13-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13 year old received the Moderna Covid 19 Vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13 year old received the Moderna Covid 19 Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medication was reported.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: administering a dose of Moderna COVID 19 vaccine to a 13 year-old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administering a dose of Moderna COVID 19 vaccine to a 13 year-old) in a 13-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administering a dose of Moderna COVID 19 vaccine to a 13 year-old). On 27-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administering a dose of Moderna COVID 19 vaccine to a 13 year-old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up information included patient demographics added, suspect route and site added.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received a dose of the Moderna COVID-19 Vaccine that expired on July 25th; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided.  No treatment medications provided.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itches; Rashes on the body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itches) and RASH (Rashes on the body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itches) and RASH (Rashes on the body). At the time of the report, PRURITUS (Itches) and RASH (Rashes on the body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.